Structure via PubChem · Public domain (PubChem)
levalbuterol
Sign in to saveAlso known as Levosalbutamol, (-)-Salbutamol, (-)-Albuterol, (R)-albuterol, (R)-salbutamol, R-salbutamol
Levosalbutamol, also known as levalbuterol, is a β2-adrenergic receptor agonist used in the treatment of bronchospasm. Levosalbutamol is the (R)-(−)-enantiomer of its prototype drug salbutamol.
Key facts
- Drug.Verifiedfields
- changed
- Drug.Watchedfields
- changed
- Drug.verifiedrevid
- 458951329
- Drug.image
- Levosalbutamol.svg
- Drug.image_class
- skin-invert-image
- Drug.width
- 225
- Drug.image2
- (R)-Salbutamol ball-and-stick model.png
- Drug.image_class2
- bg-transparent
- Drug.width2
- 225
- Drug.USAN
- levalbuterol
- Drug.tradename
- Xopenex, others
- Drug.MedlinePlus
- a603025
- Drug.DailyMedID
- Levalbuterol
- Drug.pregnancy_AU
- A
- Drug.routes_of_administration
- By mouth, inhalation
- Drug.ATC_prefix
- None
- Drug.legal_US
- Rx-only
- Drug.metabolism
- Liver
via Wikipedia infobox
Chemical data
- Formula
- C13H21NO3
- Molecular weight
- 239.31 g/mol
- IUPAC name
- 4-[(1R)-2-(tert-butylamino)-1-hydroxyethyl]-2-(hydroxymethyl)phenol
via PubChem
Drug data · ChEMBL
- Max clinical phase
- Approved
- Molecule type
- Small molecule
- First approval
- 1999
- Admin. routes
- topical
- Indications
- chronic obstructive pulmonary disease, asthma
via ChEMBL · EBI
Wikidata facts
- Mass
- 239.152
Show 4 more facts
- chemical formula
- C₁₃H₂₁NO₃
- canonical SMILES
- CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O
- isomeric SMILES
- CC(C)(C)NC[C@@H](C1=CC(=C(C=C1)O)CO)O
- Commons category
- Levosalbutamol
via Wikidata · CC0
~4 min read
Article
10 sectionsContents
- Medical use
- Comparison to salbutamol
- Adverse effects
- Pharmacology
- Mechanism of action
- Society and culture
- Economics
- Legal status
- Names
- References
Levosalbutamol, also known as levalbuterol, is a β2-adrenergic receptor agonist used in the treatment of bronchospasm. Levosalbutamol is the (R)-(−)-enantiomer of its prototype drug salbutamol.
== Medical use == Levosalbutamol is indicated for the treatment or prevention of bronchospasm in people aged four years of age and older with reversible obstructive airway disease.
Available in 10 languages
via Wikidata sitelinks · CC0